Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 117 Triple Negative Breast Neoplasms 45 Neoplasm Metastasis 11 Pancreatic Neoplasms 8 Inflammatory Breast Neoplasms 7 Breast Neoplasms, Male 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Ovarian Neoplasms 6 Carcinoma, Non-Small-Cell Lung 5 Stomach Neoplasms 4 Neoplasms 4 Lung Neoplasms 4 Carcinoma, Ductal, Breast 4 Sarcoma 3 Prostatic Neoplasms 3 Lymphoma, Non-Hodgkin 3 Endometrial Neoplasms 3 Carcinoma, Renal Cell 3 Carcinoma, Hepatocellular 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Hodgkin Disease 2 Esophageal Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Advanced Breast Cancer 2 Thrombocytosis 1 Stages II-III Breast Cancer 1 Primary Myelofibrosis 1

Interventions

Paclitaxel 3 Doxorubicin 3 Cyclophosphamide 3 Trastuzumab 2 Surgical Procedures, Operative 2 Carboplatin 2 pertuzumab 1 liposomal doxorubicin 1 cemiplimab 1 atezolizumab 1 Radiotherapy 1 Magnetic Resonance Spectroscopy 1 Lapatinib 1 Indocyanine Green 1 Anastrozole 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Invasive Breast Cancer × Albumin-Bound Paclitaxel × Breast × Clear all

NCT04243616 2025-09-05

CemiHALT

Medical College of Wisconsin

Phase 2 Active not recruiting

Invasive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡